Some factors influencing the efficiency of a jet nebuliser system
- 1 May 1990
- journal article
- research article
- Published by IOP Publishing in Clinical Physics and Physiological Measurement
- Vol. 11 (2) , 167-175
- https://doi.org/10.1088/0143-0815/11/2/007
Abstract
The operation of a commercially available nebuliser system (Medic-Aid Ltd.) is reviewed and the efficiency with which it produces an aerosol assessed. Defining the efficiency of nebulisation E as the fraction of the original mass of solution released as an aerosol it is found that the internal surface area, mass of solution used, the surface tension of the solution and the angle of tilt are important factors in determining E. Reducing the internal surface area of the nebuliser by means of Perspex inserts significantly increases E for 3 g of water from 49% for the unmodified system to 67% for the modified nebuliser (P-3 N m-1 (water) to 3.7*10-3 N m-1 and 3.1*10-3 N m-1 (using two different concentrations of a detergent in water) significantly increases E for 3 g solution from 49% to 65% and 69% respectively (P<0.05). Operating the nebuliser at a tilt also increases E.This publication has 9 references indexed in Scilit:
- Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.Thorax, 1988
- CHOICE OF NEBULIZERS AND COMPRESSORS FOR DELIVERY OF CARBENICILLIN AEROSOL1986
- Droplet size distributions of nebulised aerosols for inhalation therapyClinical Physics and Physiological Measurement, 1986
- Evaluation of jet nebulisers for use with gentamicin solution.Thorax, 1985
- NEBULISED COLOMYCIN FOR EARLY PSEUDOMONAS COLONISATION IN CYSTIC FIBROSISThe Lancet, 1985
- Therapeutic aerosols 1--physical and practical considerations.Thorax, 1983
- ASSESSMENT OF JET NEBULISERS FOR LUNG AEROSOL THERAPYThe Lancet, 1983
- Inhaled aerosols: lung deposition and clinical applicationsClinical Physics and Physiological Measurement, 1982
- AEROSOL CARBENICILLIN AND GENTAMICIN TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSISThe Lancet, 1981